Home Healthcare Biotechnology Tuberculosis Testing Market

Tuberculosis Testing Market Size, Share & Trends Analysis Report By Diagnostic Test Type (Radiographic Test, Smear Microscopy, Culture-Based Test, Nucleic Acid Test, Cytokine Detection Test, Drug Resistance Test, Other Diagnostic Test Types), By End User (Hospital/Clinic, Diagnostics/Research) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR159DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Tuberculosis Testing Market, By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
    1. Radiographic Test
    2. Smear Microscopy
    3. Culture-Based Test
    4. Nucleic Acid Test
    5. Cytokine Detection Test
    6. Drug Resistance Test
    7. Other Diagnostic Test Types
  2. Tuberculosis Testing Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospital/Clinic
    2. Diagnostics/Research
  3. Regional Tuberculosis Testing Market
    1. North America
      1. North America Tuberculosis Testing Market By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
      2. North America Tuberculosis Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital/Clinic
        2. Diagnostics/Research
      3. U.S.
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      4. Canada
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
    2. Europe
      1. Europe Tuberculosis Testing Market By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
      2. Europe Tuberculosis Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital/Clinic
        2. Diagnostics/Research
      3. U.K.
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      4. Germany
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      5. France
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      6. Spain
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      7. Italy
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      8. Russia
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      9. Nordic
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      10. Benelux
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      11. Rest of Europe
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
    3. APAC
      1. APAC Tuberculosis Testing Market By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
      2. APAC Tuberculosis Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital/Clinic
        2. Diagnostics/Research
      3. China
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      4. Korea
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      5. Japan
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      6. India
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      7. Australia
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      8. Taiwan
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      9. South East Asia
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      10. Rest of Asia-Pacific
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
    4. Middle East and Africa
      1. Middle East and Africa Tuberculosis Testing Market By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
      2. Middle East and Africa Tuberculosis Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital/Clinic
        2. Diagnostics/Research
      3. UAE
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      4. Turkey
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      5. Saudi Arabia
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      6. South Africa
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      7. Egypt
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      8. Nigeria
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      9. Rest of MEA
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
    5. LATAM
      1. LATAM Tuberculosis Testing Market By Diagnostic Test Type 2022-2034 (USD MILLION/ Units)
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
      2. LATAM Tuberculosis Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital/Clinic
        2. Diagnostics/Research
      3. Brazil
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      4. Mexico
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      5. Argentina
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      6. Chile
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      7. Colombia
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
      8. Rest of LATAM
        1. Radiographic Test
        2. Smear Microscopy
        3. Culture-Based Test
        4. Nucleic Acid Test
        5. Cytokine Detection Test
        6. Drug Resistance Test
        7. Other Diagnostic Test Types
        8. Hospital/Clinic
        9. Diagnostics/Research
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.